Literature DB >> 21122656

Management of Lp(a).

W Virgil Brown1, Christie M Ballantyne, Peter H Jones, Santica Marcovina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21122656     DOI： 10.1016/j.jacl.2010.07.002

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN： 1876-4789            Impact factor:   4.766


× No keyword cloud information.
  16 in total

Review 1.  Lipoprotein (a) measurements for clinical application.

Authors:  Santica M Marcovina; John J Albers
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

Review 2.  Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

Review 3.  Screening for and management of elevated Lp(a).

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

4.  Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.

Authors:  Lotte C A Stiekema; Erik S G Stroes; Simone L Verweij; Helina Kassahun; Lisa Chen; Scott M Wasserman; Marc S Sabatine; Venkatesh Mani; Zahi A Fayad
Journal:  Eur Heart J       Date:  2019-09-01       Impact factor: 29.983

Review 5.  Genetics of Dyslipidemia and Ischemic Heart Disease.

Authors:  Kavita Sharma; Ragavendra R Baliga
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 6.  Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.

Authors:  Michael B Boffa
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

7.  Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults.

Authors:  Azadeh Beheshtian; Sanyog G Shitole; Alan Z Segal; Dana Leifer; Russell P Tracy; Daniel J Rader; Richard B Devereux; Jorge R Kizer
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

Review 8.  Current therapies for lowering lipoprotein (a).

Authors:  Julian C van Capelleveen; Fleur M van der Valk; Erik S G Stroes
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

9.  Relationship between Lipoprotein(a) and Thyroid Hormones in Hypothyroid Patients.

Authors:  Ramachandran Kaliaperumal; Ebenezer William; Thangapaneer Selvam; Shyam M Krishnan
Journal:  J Clin Diagn Res       Date:  2014-02-03

10.  Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study.

Authors:  Rutger Verbeek; S Matthijs Boekholdt; Robert M Stoekenbroek; G Kees Hovingh; Joseph L Witztum; Nicholas J Wareham; Manjinder S Sandhu; Kay-Tee Khaw; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2016-01-31       Impact factor: 5.922
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.